VALID : VAlproate Versus LIthium in Bipolar Disorders
NCT00264173
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
270
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar Disorder
Interventions
DRUG:
Valproate sodium
Sponsor
Sanofi